Ads
related to: anticoagulant drugs- Dosing & Administration
Efficacy, Safety, and Dosing
Information for HCPs
- Co-Pay Program
Resources
to Support Your Patients
- Safety
Safety Profile - Learn About
Adverse Patient Reactions
- Request Samples
Get patients started
with a 14-day sample
- Dosing & Administration
Search results
Common heart problem ‘carries higher stroke and dementia risk than expected’
PA Media: Science via Yahoo News· 1 hour agoAmong these they identified 36,340 AF patients who had no history of stroke, a low perceived risk of...
Designing reversible anticoagulants
Nature· 5 days agoDiscover the world’s best science and medicine | Nature.com
Infarct size does not affect treatment effect of early versus late direct oral anticoagulant...
Medical Xpress· 7 days agoFor individuals with minor, moderate, or major stroke, the treatment effect of early versus late...
If You're Healthy, Daily Fish Oil Supplements Might Come With a Risk
Verywell Health via Yahoo News· 15 hours agoThe BMJ Medicine study showed that for participants with heart disease, fish oil supplements were...
Don't let bed bugs wreck your summer vacation. Here's how to avoid these bloodsuckers
AZCentral | The Arizona Republic via Yahoo News· 7 days agoThe bumps often occur in clusters or lines due to the feeding behavior of bedbugs, which usually...
Poisons targeting rodents are showing up in other wildlife
New Hampshire Union Leader· 4 days agoLast year, Maria Colby started seeing an alarming increase in the number of owls and hawks coming to...
Key Endoscopy Studies That Could Transform Your Practice
Medscape· 5 days agoDr David Johnson provides insight on 11 studies from this year's Digestive Disease Week, including...
Seaweed - The Next Trendy Superfood?
Mercola· 6 days agoData from the market research firm Mintel said that kelp seaweed could be the next rising superfood. According to a Food Navigator article,2 the firm’s data, which was acquired through their ...
First results from late-breaking Phase 3 PALOMA-3 study show five-fold reduction in infusion-related...
telegraphherald.com· 5 days agoJohnson & Johnson announced today first data from the Phase 3 PALOMA-3 study evaluating subcutaneous (SC) amivantamab combined with lazertinib in patients with locally advanced or metastatic ...
3D-printed grafts: a breakthrough in combating pos | Newswise
Newswise· 5 days agoA new study presents the development of 3D printed electrospun vascular grafts infused with...
Ad
related to: anticoagulant drugs
